Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Study shows: Transvaginal mesh is unsafe

Posted in Vaginal Mesh

The objective of a study called “Outcomes and Predictors of Failure of Trocarguided Vaginal Mesh Surgery for Pelvic Organ Prolapse”, written by the department of Obstetrics and Gynecology, Reinier de Graaf Group, and the Department of Obstetrics and Gynecology at  Radboud University Nijmegen Medical Centre in Nijmegen, The Netherlands, was to compare the outcomes of trocar-guided vaginal mesh surgery and identify predictors of failure.  Trocar refers to a sharp pointed instrument used to puncture the wall of a body cavity and withdraw fluid.  Failure outcomes were defined as prolapsed stage 2 or greater, overall prolapsed sage 2 or greater, and composite outcome of over prolapse greater than the hymen and the presence of bulge symptoms or repeat surgery.

Author Alfredo L. from the above study explains the results “The results of the study were 1 year follow-up of 433 patients. Treated compartment failure (I) was 15% (95% confidence interval [CI], 12–19). Overall prolapse failure (II) was 41% (95% CI, 36–45).  Composite failure (III) was 9% (95% CI, 7–13). Predictor of failure in all outcomes was the combined anterior/posterior mesh with the uterus in situ.”  It was found that combined anterior/posterior mesh insertion with the uterus in situ were consistent factors for failure.  Around 50 percent of women who bear multiple offspring may develop pelvic organ prolapse (POP).  It has been reported that the general population of females to the age of 85 have a 20 percent risk of undergoing surgery for POP, and increased use of prosthetic mesh in vaginal prolapse surgery is partially from the high risk involved with failure rates for native tissue repair.

The National Institutes of Health Workshop on Standardization of Terminology for Researchers in Pelvic Floor Disorders have proposed strict anatomic outcome criteria that have been used for most studies done on the subject of vaginal mesh surgery for pelvic organ prolapse.  Some studies suggest a relationship between postoperative absence of vaginal bulge symptoms and the patient’s assessment of their overall improvement.  Many researches recommend that future definitions regarding POP success should include complete absence of bulge symptoms.

Since so many vaginal mesh kits are shown by medical research teams from all over the world to have a high rate of failure, vaginal mesh lawsuits have been filed in great numbers.  If you or a loved one experienced the dangerous potential complications of vaginal mesh, you may be entitled to significant financial compensation.

For a free consultation, contact our team of vaginal mesh lawyers.  We have the experience and resources to bring you the justice you deserve.

(855) 452-5529

justinian@dangerousdrugs.us

Call today and see how we can help!

Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have any questions about Transvaginal Mesh.